339 related articles for article (PubMed ID: 9872321)
61. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
62. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.
Shiraki K; Tsuji N; Shioda T; Isselbacher KJ; Takahashi H
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6420-5. PubMed ID: 9177233
[TBL] [Abstract][Full Text] [Related]
63. Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway.
Chen PH; Yang CR
J Immunol; 2008 Dec; 181(12):8441-9. PubMed ID: 19050262
[TBL] [Abstract][Full Text] [Related]
64. Cutting edge: the tumor counterattack hypothesis revisited: colon cancer cells do not induce T cell apoptosis via the Fas (CD95, APO-1) pathway.
Favre-Felix N; Fromentin A; Hammann A; Solary E; Martin F; Bonnotte B
J Immunol; 2000 May; 164(10):5023-7. PubMed ID: 10799856
[TBL] [Abstract][Full Text] [Related]
65. Expression of Fas and Fas ligand and apoptosis in tumor-associated lymphocytes and in tumor cells from malignant pleural effusions.
Sikora J; Dworacki G; Zeromski J
Nat Immun; 1998; 16(5-6):244-55. PubMed ID: 11061592
[TBL] [Abstract][Full Text] [Related]
66. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
Shurin GV; Gerein V; Lotze MT; Barksdale EM
Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
[TBL] [Abstract][Full Text] [Related]
67. A membrane-bound Fas decoy receptor expressed by human thymocytes.
Jenkins M; Keir M; McCune JM
J Biol Chem; 2000 Mar; 275(11):7988-93. PubMed ID: 10713117
[TBL] [Abstract][Full Text] [Related]
68. Cloning and potential utility of porcine Fas ligand: overexpression in porcine endothelial cells protects them from attack by human cytolytic cells.
Tsuyuki S; Kono M; Bloom ET
Xenotransplantation; 2002 Nov; 9(6):410-21. PubMed ID: 12371937
[TBL] [Abstract][Full Text] [Related]
69. 'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells.
Toda M; Kawamoto T; Ueha T; Kishimoto K; Hara H; Fukase N; Onishi Y; Harada R; Minoda M; Kurosaka M; Akisue T
Int J Oncol; 2013 Sep; 43(3):703-12. PubMed ID: 23817777
[TBL] [Abstract][Full Text] [Related]
70. [The role of Fas/Fas ligand in tumorgenesis, immune escape, and counterattack in colonic cancer].
Zhu Q; Deng C
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):378-80. PubMed ID: 12137598
[TBL] [Abstract][Full Text] [Related]
71. Functional investigation of Fas ligand expressions in human non-small cell lung cancer cells and its clinical implications.
Lin Y; Liu L; Zhang T; Liu J
Ann Thorac Surg; 2013 Feb; 95(2):412-8. PubMed ID: 23021303
[TBL] [Abstract][Full Text] [Related]
72. Expressions of Fas/DcR3 and RGD-FasL mediated apoptosis in pituitary adenomas.
Chen L; Tian X; Li W; Agarwal A; Zhuang G
Neurol India; 2009; 57(1):28-30. PubMed ID: 19305072
[TBL] [Abstract][Full Text] [Related]
73. Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells.
Yang CR; Guh JH; Teng CM; Chen CC; Chen PH
Br J Pharmacol; 2009 Aug; 157(7):1175-85. PubMed ID: 19466993
[TBL] [Abstract][Full Text] [Related]
74. Differential increase of Fas ligand expression on metastatic and thin or thick primary melanoma cells compared with interleukin-10.
Ekmekcioglu S; Okcu MF; Colome-Grimmer MI; Owen-Schaub L; Buzaid AC; Grimm EA
Melanoma Res; 1999 Jun; 9(3):261-72. PubMed ID: 10465582
[TBL] [Abstract][Full Text] [Related]
75. [Killing effect of interleukin-18-enhanced FasL-expressing colon cancer cells on human hepatocytes in vitro].
Xu T; Hao XS; Ren XB; Zhang HL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):659-62. PubMed ID: 21122378
[TBL] [Abstract][Full Text] [Related]
76. Fas ligand-induced murine pulmonary inflammation is reduced by a stable decoy receptor 3 analogue.
Wortinger MA; Foley JW; Larocque P; Witcher DR; Lahn M; Jakubowski JA; Glasebrook A; Song HY
Immunology; 2003 Oct; 110(2):225-33. PubMed ID: 14511236
[TBL] [Abstract][Full Text] [Related]
77. Apoptosis. Death deceiver.
Green DR
Nature; 1998 Dec; 396(6712):629-30. PubMed ID: 9872307
[No Abstract] [Full Text] [Related]
78. Fas ligand expression in colon cancer: a possible mechanism of tumor immune privilege.
Zhang W; Ding EX; Wang Q; Zhu DQ; He J; Li YL; Wang YH
World J Gastroenterol; 2005 Jun; 11(23):3632-5. PubMed ID: 15962391
[TBL] [Abstract][Full Text] [Related]
79. Characterization of chicken TNFR superfamily decoy receptors, DcR3 and osteoprotegerin.
Bridgham JT; Johnson AL
Biochem Biophys Res Commun; 2003 Aug; 307(4):956-61. PubMed ID: 12878204
[TBL] [Abstract][Full Text] [Related]
80. Molecular cloning of feline Fas antigen and Fas ligand cDNAs.
Mizuno T; Endo Y; Momoi Y; Goto Y; Nishimura Y; Tsubota K; Mikami T; Ohno K; Watari T; Tsujimoto H; Hasegawa A
Vet Immunol Immunopathol; 1998 Oct; 65(2-4):161-72. PubMed ID: 9839871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
